CAPLIPOINT 株式概要
Caplin Point Laboratories Limitedは、その子会社とともに、インドにおいてジェネリック医薬品製剤およびブランド製品の開発、製造、マーケティング、輸出を行っている。
報酬
リスク分析
Caplin Point Laboratories Limited 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | ₹1,969.80 |
| 52週高値 | ₹2,158.80 |
| 52週安値 | ₹1,050.20 |
| ベータ | 0.41 |
| 11ヶ月の変化 | 0.028% |
| 3ヶ月変化 | 27.77% |
| 1年変化 | 80.48% |
| 33年間の変化 | 131.80% |
| 5年間の変化 | 413.24% |
| IPOからの変化 | 5,402.23% |
最新ニュース
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 31
Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50
Sep 12Recent updates
With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 31Caplin Point Laboratories (NSE:CAPLIPOINT) Is Due To Pay A Dividend Of ₹2.50
Sep 12Earnings Update: Here's Why Analysts Just Lifted Their Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Price Target To ₹1,764
Aug 11Caplin Point Laboratories (NSE:CAPLIPOINT) Is Paying Out A Dividend Of ₹2.50
Aug 10Investors Aren't Buying Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Earnings
Jul 12Caplin Point Laboratories (NSE:CAPLIPOINT) Strong Profits May Be Masking Some Underlying Issues
May 24Does Caplin Point Laboratories (NSE:CAPLIPOINT) Deserve A Spot On Your Watchlist?
May 04Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Low P/E No Reason For Excitement
Mar 07With EPS Growth And More, Caplin Point Laboratories (NSE:CAPLIPOINT) Makes An Interesting Case
Oct 24Why We Think The CEO Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT) May Soon See A Pay Rise
Sep 15Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹2.50
Aug 11We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise
Sep 23Caplin Point Laboratories' (NSE:CAPLIPOINT) Shareholders Will Receive A Bigger Dividend Than Last Year
Sep 11Is Now The Time To Put Caplin Point Laboratories (NSE:CAPLIPOINT) On Your Watchlist?
Jul 22Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹2.00
May 15A Look At The Intrinsic Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Jan 21Should You Be Adding Caplin Point Laboratories (NSE:CAPLIPOINT) To Your Watchlist Today?
Oct 20Caplin Point Laboratories (NSE:CAPLIPOINT) Is Increasing Its Dividend To ₹1.50
Sep 17Caplin Point Laboratories (NSE:CAPLIPOINT) Will Pay A Larger Dividend Than Last Year At ₹1.50
Sep 03Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Intrinsic Value Is Potentially 28% Above Its Share Price
Aug 27Is Caplin Point Laboratories (NSE:CAPLIPOINT) A Risky Investment?
Jun 12Estimating The Fair Value Of Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
Apr 29Does Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Have A Place In Your Dividend Portfolio?
Mar 24株主還元
| CAPLIPOINT | IN Pharmaceuticals | IN 市場 | |
|---|---|---|---|
| 7D | 9.1% | 2.0% | 1.8% |
| 1Y | 80.5% | 58.6% | 36.8% |
業界別リターン: CAPLIPOINT exceeded the Indian Pharmaceuticals industry which returned 58.6% over the past year.
リターン対市場: CAPLIPOINT exceeded the Indian Market which returned 36.8% over the past year.
価格変動
| CAPLIPOINT volatility | |
|---|---|
| CAPLIPOINT Average Weekly Movement | 8.4% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
安定した株価: CAPLIPOINT's share price has been volatile over the past 3 months compared to the Indian market.
時間の経過による変動: CAPLIPOINT's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1990 | 3,406 | Sridhar Ganesan | www.caplinpoint.net |
Caplin Point Laboratories Limited は子会社とともに、インドでジェネリック医薬品製剤およびブランド製品の開発、製造、マーケティング、輸出を行っている。同社は、錠剤、カプセル剤、注射剤、眼科用剤、液体経口剤、ソフトジェルカプセル剤、軟膏剤、クリーム剤、ゲル剤、注射用粉末剤、坐剤、卵剤、プレミックスバッグ剤、吸入剤、スプレー剤、点滴剤を提供している。また、ドライシロップ、凍結乾燥バイアル、プレフィルドシリンジ、乳剤注射剤、外用剤も提供している。Caplin Point Laboratories Limitedは1990年に設立され、インドのチェンナイに本社を置く。
Caplin Point Laboratories Limited 基礎のまとめ
| CAPLIPOINT 基礎統計学 | |
|---|---|
| 時価総額 | ₹149.44b |
| 収益（TTM） | ₹4.78b |
| 売上高(TTM) | ₹17.58b |
31.3x
PER（株価収益率8.5x
P/SレシオCAPLIPOINT は割高か？
公正価値と評価分析を参照収益と収入
| CAPLIPOINT 損益計算書（TTM） | |
|---|---|
| 収益 | ₹17.58b |
| 売上原価 | ₹7.33b |
| 売上総利益 | ₹10.25b |
| その他の費用 | ₹5.47b |
| 収益 | ₹4.78b |
直近の収益報告
Jun 30, 2024
次回決算日
Nov 07, 2024
| 一株当たり利益（EPS） | 62.84 |
| グロス・マージン | 58.30% |
| 純利益率 | 27.17% |
| 有利子負債／自己資本比率 | 0.08% |
CAPLIPOINT の長期的なパフォーマンスは？
過去の実績と比較を見る